Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
If you ask why you keep overspending, you're not alone. This section breaks down frequent triggers and offers concrete fixes to align spending with goals.
22,598 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
AI-driven momentum puts Apple on a path to a potential $6 trillion valuation, as investors weigh WWDC 2026 plans and ...
Home Depot's Q1 2026 results provide a window into consumer demand, mix shifts, and profitability. This article break...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...
Wells Fargo lowers Meta's price target to 765 but preserves a bullish view as Meta reports strong Q1 FY2026 results a...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
Stephen Colbert signs after 11 years hosting The Late Show, as CBS cites financial reasons for the end and Colbert ac...
NIO reports its first-ever quarterly profit, but shares fall while Tesla leads a modest rally, illustrating the two-s...
A Google-backed pilot is testing a portal-like model that surfaces MLS-listed homes via search, changing how buyers a...
ON Semiconductor climbs to fresh highs in 2026 as AI data-center demand and GaN power tech power a strong cash flow-l...
Descendants seek access to historical mental health records to inform family finances, risk, and care planning as sta...